Stabilisation of Laryngeal AL Amyloidosis with Long Term Curcumin Therapy.

about

Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leu B-Cell Disorders and Curcumin.

P2860

Q40684364-10C2CA51-482F-41ED-96F9-306CB4FF7132 Q49773570-C3B65B80-0D5A-430E-B87C-4946F9DB05F4

P2860

Stabilisation of Laryngeal AL Amyloidosis with Long Term Curcumin Therapy.

Item

http://www.wikidata.org/entity/Q35833408

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Stabilisation of Laryngeal AL Amyloidosis with Long Term Curcumin Therapy.

@ast

Stabilisation of Laryngeal AL Amyloidosis with Long Term Curcumin Therapy.

@en

type

Item

label

Stabilisation of Laryngeal AL Amyloidosis with Long Term Curcumin Therapy.

@ast

Stabilisation of Laryngeal AL Amyloidosis with Long Term Curcumin Therapy.

@en

prefLabel

Stabilisation of Laryngeal AL Amyloidosis with Long Term Curcumin Therapy.

@ast

Stabilisation of Laryngeal AL Amyloidosis with Long Term Curcumin Therapy.

@en

P1476

Stabilisation of Laryngeal AL Amyloidosis with Long Term Curcumin Therapy.

@en

P2093

Arumugam Manoharan

http://www.w3.org/2001/XMLSchema#string

Rajeev Ramakrishna

http://www.w3.org/2001/XMLSchema#string

Terrence H Diamond

http://www.w3.org/2001/XMLSchema#string

Terry Golombick

http://www.w3.org/2001/XMLSchema#string

P2860

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial.

Amyloidosis.

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy.

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.

Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study.

The potential role of curcumin in patients with monoclonal gammopathy of undefined significance--its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker.

Curcumin and neurodegenerative diseases.

The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia.

P304

910528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/910528

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280392555

http://www.w3.org/2001/XMLSchema#string

P698

26199769

http://www.w3.org/2001/XMLSchema#string

P921

curcumin

Bagtingan

P932

4496470

http://www.w3.org/2001/XMLSchema#string

Stabilisation of Laryngeal AL Amyloidosis with Long Term Curcumin Therapy.

about

P2860

P2860

Stabilisation of Laryngeal AL Amyloidosis with Long Term Curcumin Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932